170 related articles for article (PubMed ID: 20568114)
1. Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src.
Bu Y; Gao L; Gelman IH
Int J Cancer; 2011 Apr; 128(8):1836-42. PubMed ID: 20568114
[TBL] [Abstract][Full Text] [Related]
2. v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex.
Bu Y; Gelman IH
J Biol Chem; 2007 Sep; 282(37):26725-26739. PubMed ID: 17626016
[TBL] [Abstract][Full Text] [Related]
3. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway.
Su B; Bu Y; Engelberg D; Gelman IH
J Biol Chem; 2010 Feb; 285(7):4578-86. PubMed ID: 20018890
[TBL] [Abstract][Full Text] [Related]
4. SSeCKS/Gravin/AKAP12 metastasis suppressor inhibits podosome formation via RhoA- and Cdc42-dependent pathways.
Gelman IH; Gao L
Mol Cancer Res; 2006 Mar; 4(3):151-8. PubMed ID: 16547152
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the Grp78 promoter by endoplasmic reticulum stress: role of TFII-I and its tyrosine phosphorylation.
Hong M; Lin MY; Huang JM; Baumeister P; Hakre S; Roy AL; Lee AS
J Biol Chem; 2005 Apr; 280(17):16821-8. PubMed ID: 15664986
[TBL] [Abstract][Full Text] [Related]
6. SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis.
Liu Y; Gao L; Gelman IH
BMC Cancer; 2006 Apr; 6():105. PubMed ID: 16638134
[TBL] [Abstract][Full Text] [Related]
7. Adhesion-mediated cytoskeletal remodeling is controlled by the direct scaffolding of Src from FAK complexes to lipid rafts by SSeCKS/AKAP12.
Su B; Gao L; Meng F; Guo LW; Rothschild J; Gelman IH
Oncogene; 2013 Apr; 32(16):2016-26. PubMed ID: 22710722
[TBL] [Abstract][Full Text] [Related]
8. Loss of the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia.
Akakura S; Huang C; Nelson PJ; Foster B; Gelman IH
Cancer Res; 2008 Jul; 68(13):5096-103. PubMed ID: 18593908
[TBL] [Abstract][Full Text] [Related]
9. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.
Lin X; Gelman IH
Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-induced, FAK-dependent tyrosine phosphorylation of the SSeCKS scaffolding protein.
Xia W; Gelman IH
Exp Cell Res; 2002 Jul; 277(2):139-51. PubMed ID: 12083796
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha inhibits Schwann cell proliferation by up-regulating Src-suppressed protein kinase C substrate expression.
Tao T; Ji Y; Cheng C; Yang H; Liu H; Sun L; Qin Y; Yang J; Wang H; Shen A
J Neurochem; 2009 Nov; 111(3):647-55. PubMed ID: 19694904
[TBL] [Abstract][Full Text] [Related]
12. SSeCKS/Gravin/AKAP12 Inhibits PKCĪ¶-Mediated Reduction of ERK5 Transactivation to Prevent Endotoxin-Induced Vascular dysfunction.
Li Z; Hu J; Guo J; Fan L; Wang S; Dou N; Zuo J; Yu S
Cardiovasc Toxicol; 2019 Aug; 19(4):372-381. PubMed ID: 30805771
[TBL] [Abstract][Full Text] [Related]
13. Positive and negative regulation of the transforming growth factor beta/activin target gene goosecoid by the TFII-I family of transcription factors.
Ku M; Sokol SY; Wu J; Tussie-Luna MI; Roy AL; Hata A
Mol Cell Biol; 2005 Aug; 25(16):7144-57. PubMed ID: 16055724
[TBL] [Abstract][Full Text] [Related]
14. A role for SSeCKS, a major protein kinase C substrate with tumour suppressor activity, in cytoskeletal architecture, formation of migratory processes, and cell migration during embryogenesis.
Gelman IH; Tombler E; Vargas J
Histochem J; 2000 Jan; 32(1):13-26. PubMed ID: 10805381
[TBL] [Abstract][Full Text] [Related]
15. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
Xia W; Unger P; Miller L; Nelson J; Gelman IH
Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
[TBL] [Abstract][Full Text] [Related]
16. Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12.
Akakura S; Nochajski P; Gao L; Sotomayor P; Matsui S; Gelman IH
Cell Cycle; 2010 Dec; 9(23):4656-65. PubMed ID: 21099353
[TBL] [Abstract][Full Text] [Related]
17. Control of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12.
Guo LW; Gao L; Rothschild J; Su B; Gelman IH
J Biol Chem; 2011 Nov; 286(44):38356-38366. PubMed ID: 21903576
[TBL] [Abstract][Full Text] [Related]
18. Cell-cycle regulated expression and serine phosphorylation of the myristylated protein kinase C substrate, SSeCKS: correlation with culture confluency, cell cycle phase and serum response.
Nelson PJ; Gelman IH
Mol Cell Biochem; 1997 Oct; 175(1-2):233-41. PubMed ID: 9350056
[TBL] [Abstract][Full Text] [Related]
19. A critical role of SRC-suppressed C kinase substrate in rat astrocytes after chronic constriction injury.
Xia Y; Liu H; Shen A; Liu Y; Sun L; Tao T; Ke Q; Cheng C
Neuromolecular Med; 2010 Sep; 12(3):205-16. PubMed ID: 19937403
[TBL] [Abstract][Full Text] [Related]
20. Control of cytoskeletal architecture by the src-suppressed C kinase substrate, SSeCKS.
Gelman IH; Lee K; Tombler E; Gordon R; Lin X
Cell Motil Cytoskeleton; 1998; 41(1):1-17. PubMed ID: 9744295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
